My Allergist Dad
On this episode of My Allergist Dad, Drew and Dr. Z talk with Dr. Jonathan Friedlander, Chief Business Officer at Atanis Biotech about FAST-PASE®, a diagnostic test that uses a stable, functional engineered mast cell line to measure whether a patient’s serum actually triggers mast cell activation when exposed to specific allergens. Unlike basophil activation testing that requires fresh whole blood, FAST-PASE® removes cells, uses serum to sensitize lab mast cells with the patient’s IgE, IgG, and other factors, then adds allergens at multiple concentrations and measures activation, aiming to reduce false positives from IgE-only tests and better predict clinical reactivity and thresholds for oral food challenges. They discuss applications to food allergy, immunotherapy monitoring (OIT/SLIT), alpha-gal syndrome and widespread sensitization vs true allergy, and broader future uses for environmental allergens and drug allergy, plus Jonathan’s recent Capitol Hill visit and plans to start testing at Dr. Z’s clinic.00:00 Basophil Test Limits00:59 Why This Test Matters01:56 Show Intro and Guest04:18 Origins of Atanis Biotech06:16 Immortal Mast Cells08:08 How FAST-PASE® Works10:08 Compared to IgE Tests13:32 IgG Protection Nuance16:02 Desensitization and Challenges17:55 Alpha Gal Confusion19:25 Alpha Gal Biology21:04 Need Functional Testing22:37 Tick Season Anxiety23:12 Alpha Gal Case Story23:52 Hidden Alpha Gal Exposures24:31 Gene Edited Pig Organs24:46 Sausage Trial And Food Questions26:26 Therapies And Monitoring Progress28:30 Beyond Food Allergens29:35 Drug Allergy And Testing Limits30:54 Advocacy On Capitol Hill32:56 Access And Allergist Shortage34:07 Mast Cell Confusion And Root Causes36:55 Launching In Europe Too39:15 Wrap Up And Next Steps40:24 Clinic Testing And Farewell📩 Have a question for the show?Email: myallergistdad@gmail.com
27 episodios
Comentarios
0Sé la primera persona en comentar
¡Regístrate ahora y únete a la comunidad de My Allergist Dad!